Taxis Are About To Get Wings (and Your Portfolio Too)

Flying cars stopped being a sci-fi punchline the moment Washington gave the nod. Pilot programs, FAA milestones, and app integrations are lining up to turn this “someday” story into “sooner than you think.” You’ll want to be in before liftoff.

A Message From HUB Cyber Security Ltd.

Some stocks grind higher for years. Others can move in days.

The difference often comes down to supply.

In this case, the supply is razor-thin. Just 9.7 million shares in the float, leaving very little paper available to trade.

Now imagine what happens when fresh demand hits a float this small. It’s like a spark in dry grass. Moves can be fast, powerful, and hard to ignore.

That setup is already in motion.

This company just landed a $25 million recurring compliance contract, a $23 million (€20M) European banking overhaul, and raised $20 million to accelerate US expansion. Each milestone makes it harder for Wall Street to overlook what’s happening here.

Yet the valuation is still microscopic: $21 million market cap.

Compare that to Palantir at $366B, Snowflake at $73B, or CrowdStrike at $103B. They dominate headlines, but they don’t solve the same problem this company does: securing and automating compliance at the very core of financial data.

When news breaks again, there won’t be enough stock to go around.

That’s why investors who recognize the scarcity dynamic are paying attention now, before the crowd wakes up.

See the full story before the next contract hits.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Elon’s billion-dollar YOLO is giving futures a morning buzz, while you sip coffee and wait for Powell’s big rate-cut call later this week.

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.

Email’s great. Texts are faster.

👉 Click here to get our pre-market report to your cell for free!

You’ll be first in line when the market starts moving.

Premarket Earnings:

Aftermarket Earnings:

Economic Reports:

If you like getting paid to wait, this one’s speaking your language. At today’s prices, you’re looking at a dividend yield north of 7%, that’s roughly $740 a year on every $10K you park here, with a history of steady raises.

The reason the yield looks fat is the flip side of the coin. The stock’s been knocked around by fading COVID revenues, looming patent cliffs (Eliquis, Prevnar, Ibrance, etc.), and policy noise. That’s why valuation screens cheap on forward P/E and price-to-sales versus big-pharma peers.

Here’s the part you should care about, though. The business mix is shifting. Oncology is getting real weight after the Seagen deal, late-stage assets are stacking up, and management’s carving out multi-billion cost savings through 2027. You’re not buying a growth rocket, you’re buying a cash-rich refit with optionality if the pipeline hits.

Why it Matters: You want durable income with a shot at upside if new launches offset the loss-of-exclusivity dip. Lower volatility than high-beta biotech, more juice than a low-yield bond.

Your Investor Takeaway: If you’re income-first, you’ll see opportunity to dollar-cost average and let the dividend drip do the work. If you’re total-return focused, demand proof, with oncology acceleration, clean readouts, and progress on that savings plan. Position size like a core income sleeve, then add on execution, not hope.

When a company adds $1B to its buyback, taking authorization to $7B, it’s saying, “we like our stock at these levels.” After a bruising selloff (down ~50% YTD), the setup is classic: solid cash flow, modest growth in core “Insights,” and a valuation that finally looks mortal instead of mythic.

The catch is that guidance cooled, contract value growth is single digits, and clients are still debating budgets while everyone tosses the word “AI” like confetti.

This is a subscription engine with long customer relationships, sticky research, and consulting that hums when CFOs reopen the purse. You’re not chasing hype here, as much as you’re underwriting durability plus financial engineering. Buybacks don’t fix strategy, but they do reduce share count and boost per-share optics while the story resets.

Why it Matters: If you believe in the recurring-revenue model and the moat around proprietary research, dislocations like this are where multi-year positions are born, not at 30x earnings on euphoria.

Your Investor Takeaway: You’ll see opportunity if you think the market overshot on the way down. Let it base, watch renewal metrics and CV growth, then scale in. Use the buyback as your floor guide, because if management’s buying aggressively and fundamentals stabilize, you can, too. If not, keep it on a watchlist and wait for higher-highs confirmation.

Most portfolios deliver “average.”

But if you’re reading this, you’re not after average.

That’s why our team just unveiled 5 carefully selected stocks with the potential to deliver massive upside.

What sets them apart?

Past reports from this series have highlighted stocks that posted gains of +175%, +498%, and even +673%.

Now, it’s your chance to see the latest 5 picks—completely free.

Click here to claim your copy before midnight tonight

Extraordinary opportunities don’t come often. Don’t miss this one.

You want futuristic, but with a plan? Joby just checked two boxes. First, it’s joining the White House’s eVTOL pilot program, the real-world testing for passenger, cargo, and emergency ops ahead of full FAA approval.

Second, it’s lining up distribution. Integrating helicopter and seaplane rides (via the Blade deal) into the Uber app as soon as next year, then swapping in its quieter, all-electric birds as certification finishes. That means trial data on the back end, demand plumbing on the front end.

The company says it’s in phase 4 of 5 for FAA type certification, with its first conforming aircraft due this year and FAA pilot testing targeted for early 2026. Markets love visible milestones, and this name has them, with certification steps, city launches (Dubai, New York, LA, UK, Japan), and app exposure that makes discovery dumb-simple for riders. High risk? Yep. But the glide path is clearer than the average moonshot.

Why it Matters: You’re not betting on sci-fi, you’re betting on execution across regulation, manufacturing, and ops. Plus, the network effect of showing up inside the most downloaded ride-hailing app.

Your Investor Takeaway: Trade the milestones, with green lights on certification phases and partnership updates. If you’re investing, size it like venture-beta with a small core, to add on validated progress, and keep an exit plan in case timelines slip.

Elon just wrote himself a billion-dollar love letter, scooping up 2.6M shares to beef up his stake. You can see it as a signal of conviction (or maybe just a power play for that new $1T comp plan).

Either way, the tape lit up, and TSLA’s back over $420, memes included.

Retail’s strapping in as Archer joins a federal air-taxi pilot program. Add chatter about airline tie-ups and you’ve got Stocktwits buzzing like it’s 2021 again.

Bears are pointing at the 15% short interest, while bulls are already sketching $20 flight paths.

Oil junior’s bouncing despite lawsuits over allegedly “misleading” production claims. Analysts keep slapping Buy ratings with $30–$47 targets, but the legal overhang makes this one a tug-of-war.

For now, the tide’s in its favor.

The escalating trade tensions are reshaping the AI market.

With Washington tightening export restrictions on advanced AI chips to China, giants like Nvidia face steep revenue losses.

This disruption creates a rare opening for U.S.-based AI innovators, and I’ve pinpointed 9 under-the-radar companies with:

Get all 9 tickers, financials, and growth forecasts in my free report: “Top 9 AI Stocks for This Month.”

Markets are moving fast—catch these plays before the crowd.

[Download Free Now]

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.